Drug profile · INN
acetylcysteine lysine
LEGUBETI
acetylcysteine lysine (LEGUBETI) is a glutathione precursor. Route of administration: oral. Current US regulatory status: approved.
Drug details — acetylcysteine lysine
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
acetylcysteine lysine (LEGUBETI) is a glutathione precursor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Glutathione precursor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is acetylcysteine lysine?
acetylcysteine lysine (LEGUBETI) is a glutathione precursor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for acetylcysteine lysine?
LEGUBETI is a marketed brand name for acetylcysteine lysine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of acetylcysteine lysine?
acetylcysteine lysine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.